Correlation Between Regeneron Pharmaceuticals and Willamette Valley
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Willamette Valley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Willamette Valley into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Willamette Valley Vineyards, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Willamette Valley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Willamette Valley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Willamette Valley.
Diversification Opportunities for Regeneron Pharmaceuticals and Willamette Valley
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Regeneron and Willamette is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Willamette Valley Vineyards in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Willamette Valley and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Willamette Valley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Willamette Valley has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Willamette Valley go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Willamette Valley
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Willamette Valley. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 1.08 times less risky than Willamette Valley. The stock trades about -0.06 of its potential returns per unit of risk. The Willamette Valley Vineyards is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 344.00 in Willamette Valley Vineyards on December 23, 2024 and sell it today you would lose (8.00) from holding Willamette Valley Vineyards or give up 2.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Regeneron Pharmaceuticals vs. Willamette Valley Vineyards
Performance |
Timeline |
Regeneron Pharmaceuticals |
Willamette Valley |
Regeneron Pharmaceuticals and Willamette Valley Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regeneron Pharmaceuticals and Willamette Valley
The main advantage of trading using opposite Regeneron Pharmaceuticals and Willamette Valley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Willamette Valley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willamette Valley will offset losses from the drop in Willamette Valley's long position.Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Willamette Valley vs. Naked Wines plc | Willamette Valley vs. Pernod Ricard SA | Willamette Valley vs. Brown Forman | Willamette Valley vs. Treasury Wine Estates |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |